
|Videos|November 16, 2020
(AAO) Study outlines use of injectable intraocular steroid over drops
Author(s)OT Staff Reports
Robert Weinstock, MD, presents data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery.
Advertisement
Robert Weinstock, MD, director of Cataract & Refractive Surgery, The Eye Institute of West Florida; the Weinstock Laser Eye Center, presents real-world data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery.
Weinstock notes that research shows the injections can decrease inflammation and control IOP.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: Uveitis or retinitis pigmentosa? Ester Carreño, MD, PhD, on mimics
2
EURETINA 2026: Retinal signs as diagnostic clues to systemic metabolic disease
3
EURETINA 2026: Gene therapy sessions to watch in Vienna
4
What retinal imaging reveals about the brain-eye connection with Sharon Fekrat, MD, FACS, FASRS
5
















